Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-23-011342

SVP, Chief Marketing Officer acquired 32,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wijkstrom Joakim SVP, Chief Marketing Officer 2023-02-16 Grant or award +32,700 129,373 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wijkstrom Joakim SVP, Chief Marketing Officer 2023-02-16 Grant or award · Stock Option (Right to Buy) +77,500 77,500 D: show line 2 in the form
Loading xslF345X03/doc4.xml…